(Q33523157)

27 July 2017

title

How do patients with inflammatory bowel disease want their biological therapy administered? (English)

1 reference

inflammatory bowel diseases

27 July 2017

main subject

0 references

inflammation

0 references

author name string

Patrick B Allen

series ordinal

1

1 reference

27 July 2017

Hannah Lindsay

series ordinal

2

1 reference

27 July 2017

Tony C K Tham

series ordinal

3

1 reference

27 July 2017

publication date

10 January 2010

1 reference

27 July 2017

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

page(s)

1

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

copyright license

start time

10 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Osteoporosis medication profile preference: results from the PREFER-US study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Not all patients want to participate in decision making. A national study of public preferences

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Treatment preference and tolerability with alendronate once weekly over a 3-month period: an Israeli multi-center study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Patient-doctor communication

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Patients have treatment preferences: a multicentre, double-blind, crossover study comparing rabeprazole and omeprazole

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Partnerships with patients: the pros and cons of shared clinical decision-making

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Sharing decisions with patients: is the information good enough?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-1

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-1

Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-1

Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-1

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-1

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-1

Patients with osteoporosis prefer once weekly to once daily dosing with alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-1

Infliximab prevents Crohn's disease recurrence after ileal resection

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

Quality of life in inflammatory bowel disease.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817682

A new measure of health status for clinical trials in inflammatory bowel disease

31 October 2018

1 reference

12 December 2020

Shared decision making in the real world

1 reference

12 December 2020

Moving toward a more patient-centered health care delivery system

1 reference

12 December 2020

Patient preferences in choosing anti-TNF therapies-R1

1 reference

12 December 2020

Permanent work disability in Crohn's disease

1 reference

12 December 2020

Treatment choices, preferences and decision-making by patients with rheumatoid arthritis

1 reference

12 December 2020

Adalimumab for Crohn's disease with intolerance or lost response to infliximab: a 3-year single-centre experience

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-10-1

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference